Hall Capital Management Co. Inc. cut its holdings in CVS Health Corp (NYSE:CVS) by 37.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,711 shares of the pharmacy operator’s stock after selling 7,050 shares during the quarter. Hall Capital Management Co. Inc.’s holdings in CVS Health were worth $849,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of CVS Health by 1.4% in the second quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock valued at $6,159,825,000 after buying an additional 1,056,265 shares in the last quarter. FMR LLC boosted its stake in shares of CVS Health by 22.0% in the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after buying an additional 5,446,930 shares in the last quarter. Northern Trust Corp boosted its stake in shares of CVS Health by 5.5% in the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock valued at $1,256,631,000 after buying an additional 807,639 shares in the last quarter. Nordea Investment Management AB boosted its position in CVS Health by 8.4% during the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after purchasing an additional 1,100,373 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in CVS Health by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 10,856,659 shares of the pharmacy operator’s stock worth $882,860,000 after purchasing an additional 430,377 shares in the last quarter. Hedge funds and other institutional investors own 83.96% of the company’s stock.
A number of research firms have commented on CVS. Morgan Stanley upgraded CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 target price on the stock in a research report on Friday, January 5th. Needham & Company LLC boosted their target price on CVS Health from $85.00 to $88.00 and gave the stock a “buy” rating in a research report on Tuesday, January 2nd. SunTrust Banks boosted their target price on CVS Health to $90.00 and gave the stock a “buy” rating in a research report on Friday, January 5th. Leerink Swann set a $85.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, Mizuho set a $95.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. CVS Health has an average rating of “Buy” and a consensus price target of $87.03.
Shares of CVS Health stock opened at $65.65 on Monday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. CVS Health Corp has a 12-month low of $65.65 and a 12-month high of $84.00. The stock has a market capitalization of $66,604.02, a price-to-earnings ratio of 10.15, a PEG ratio of 1.09 and a beta of 1.03.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business had revenue of $48.39 billion for the quarter, compared to the consensus estimate of $47.54 billion. During the same period in the prior year, the business earned $1.71 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. sell-side analysts anticipate that CVS Health Corp will post 6.37 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be given a $0.50 dividend. The ex-dividend date is Friday, April 20th. This represents a $2.00 annualized dividend and a dividend yield of 3.05%. CVS Health’s dividend payout ratio is currently 30.91%.
COPYRIGHT VIOLATION WARNING: This story was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.com-unik.info/2018/03/19/hall-capital-management-co-inc-has-849000-position-in-cvs-health-corp-cvs.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.